EP 0610345 B1 20000712 - COMBINED CELLULAR AND IMMUNOSUPPRESSIVE THERAPIES
Title (en)
COMBINED CELLULAR AND IMMUNOSUPPRESSIVE THERAPIES
Title (de)
KOMBINIERTE ZELLULÄRE UND IMMUNSUPPRESSIVE THERAPIEN
Title (fr)
THERAPIES CELLULAIRES ET IMMUNO-SUPPRESSIVES COMBINEES
Publication
Application
Priority
- US 9208969 W 19921014
- US 78107591 A 19911021
Abstract (en)
[origin: US5670148A] Novel regimens are provided for administering foreign genetically modified allogeneic cells to a host by combining the administration of the cells with a reduced regimen of an immunosuppressive agent. Particularly, cells having a reduced level of Class I MHC antigens may be employed in a variety of cellular therapy situations, where foreign cells are engrafted to treat diseased states.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 35/12 (2006.01); A61K 35/36 (2015.01); A61K 38/13 (2006.01); A61K 39/00 (2006.01); A61P 37/06 (2006.01)
CPC (source: EP US)
A61K 31/436 (2013.01 - EP US); A61K 35/36 (2013.01 - EP US); A61K 38/13 (2013.01 - EP US); A61K 39/001 (2013.01 - EP US); A61P 37/06 (2018.01 - EP); C12N 2510/00 (2013.01 - EP US)
C-Set (source: EP US)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE
DOCDB simple family (publication)
US 5670148 A 19970923; AT E194494 T1 20000715; AU 2883192 A 19930521; CA 2121487 A1 19930429; DE 69231250 D1 20000817; DE 69231250 T2 20010315; DK 0610345 T3 20001023; EP 0610345 A1 19940817; EP 0610345 A4 19970115; EP 0610345 B1 20000712; ES 2150424 T3 20001201; GR 3034510 T3 20001229; JP H07500343 A 19950112; WO 9307887 A1 19930429
DOCDB simple family (application)
US 31445294 A 19940928; AT 92922624 T 19921014; AU 2883192 A 19921014; CA 2121487 A 19921014; DE 69231250 T 19921014; DK 92922624 T 19921014; EP 92922624 A 19921014; ES 92922624 T 19921014; GR 20000402200 T 20000928; JP 50788993 A 19921014; US 9208969 W 19921014